| Typicality: | 0.592 |
| Saliency: | 0.422 |
| since under the name | 7 | temporal |
| more recently, | 6 | temporal |
| widely | 4 | degree |
| drug → be available in → the united states | 25 |
| drug → be available in → the us | 21 |
| drug → be available in → the u.s. | 13 |
| drug → be available in → the usa | 8 |
| drug → be on → the u.s. market | 4 |
| negative | neutral | positive |
| 0.183 | 0.642 | 0.175 |
| Raw frequency | 71 |
| Normalized frequency | 0.422 |
| Modifier score | 1.000 |
| Perplexity | 18.364 |